CLINICAL_TRIALS trial_result · 2024-10-24

Clinical Trial Update: A Study of the Efficacy, Safety and Tolerability of Chronocort in Treating CAH [Phase 3]

Phase 3 trial evaluating Chronocort for congenital adrenal hyperplasia has completed with posted results assessing efficacy, safety and tolerability.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Neurocrine UK Limited | Conditions: Congenital Adrenal Hyperplasia | Phase 3 | Status: COMPLETED | Results posted: 2024-10-24